首页 > 最新文献

Clinical laboratory最新文献

英文 中文
Identification of a Novel Mutation in B Allele in a Chinese Individual. 在一名中国人身上发现 B 等位基因的新型突变
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240602
Haijuan Wang, Hong Zhao, Jian Chen, Jing Feng, Guojin Ou

Background: There are 49 B alleles in the ISBT ABO blood group list. This study will describe a new missense mutation, c.784G>T, in exon 7 of the ABO in a Chinese individual.

Methods: A weak B was analyzed by serologic techniques. Exons 6 and 7 were sequenced directly through polymerase chain reaction-based typing (PCR-SBT). Subsequently, the heterozygous mutation sites in exon 7 were determined through cloning and sequencing. The mutated GTB proteins were expressed in HEK293F cells after being subcloned into a pCAG vector with a Strep-tag. The potential impact of the mutations on GTB stability was predicted using mCSM software, while UCSF Chimera X software was utilized for visualization of the mutation.

Results: The ABO blood typing of serologic characteristics showed weak B phenotype, and the heterozygous site ABO*B.01 (c.784G>T) in Exon 7 was identified by PCR-SBT analysis after TA cloning, which led to an alteration of Asp to Tyr at residue 262 in B glycosyltransferase. Like the ABO*BW.17 (D262Y), D262N also significantly de-creased ABO*B.01 expression and lead to GTB destabilizing.

Conclusions: The novel B allele with 784G>T caused an alteration of Asp to Tyr at residue 262 in B glycosyltransferase, affecting the expression of GTB protein and influencing GTB structural instability.

背景:在 ISBT ABO 血型列表中有 49 个 B 等位基因。本研究将描述一名中国人 ABO 血型第 7 外显子中的一个新的错义突变 c.784G>T:方法:通过血清学技术分析了一个弱 B 型血。通过基于聚合酶链反应的分型(PCR-SBT)直接对第 6 和第 7 外显子进行测序。随后,通过克隆和测序确定了外显子 7 中的杂合突变位点。将突变的 GTB 蛋白亚克隆到带有 Strep 标记的 pCAG 载体后,在 HEK293F 细胞中进行了表达。利用 mCSM 软件预测了突变对 GTB 稳定性的潜在影响,同时利用 UCSF Chimera X 软件对突变进行了可视化:ABO血型的血清学特征显示为弱B表型,TA克隆后通过PCR-SBT分析确定了外显子7中的杂合位点ABO*B.01(c.784G>T),该位点导致B糖基转移酶中残基262处的Asp变为Tyr。与ABO*BW.17(D262Y)一样,D262N也会显著降低ABO*B.01的表达,并导致GTB不稳定:结论:784G>T的新型B等位基因导致B糖基转移酶262位残基的Asp变为Tyr,影响了GTB蛋白的表达,并导致GTB结构不稳定。
{"title":"Identification of a Novel Mutation in B Allele in a Chinese Individual.","authors":"Haijuan Wang, Hong Zhao, Jian Chen, Jing Feng, Guojin Ou","doi":"10.7754/Clin.Lab.2024.240602","DOIUrl":"10.7754/Clin.Lab.2024.240602","url":null,"abstract":"<p><strong>Background: </strong>There are 49 B alleles in the ISBT ABO blood group list. This study will describe a new missense mutation, c.784G>T, in exon 7 of the ABO in a Chinese individual.</p><p><strong>Methods: </strong>A weak B was analyzed by serologic techniques. Exons 6 and 7 were sequenced directly through polymerase chain reaction-based typing (PCR-SBT). Subsequently, the heterozygous mutation sites in exon 7 were determined through cloning and sequencing. The mutated GTB proteins were expressed in HEK293F cells after being subcloned into a pCAG vector with a Strep-tag. The potential impact of the mutations on GTB stability was predicted using mCSM software, while UCSF Chimera X software was utilized for visualization of the mutation.</p><p><strong>Results: </strong>The ABO blood typing of serologic characteristics showed weak B phenotype, and the heterozygous site ABO*B.01 (c.784G>T) in Exon 7 was identified by PCR-SBT analysis after TA cloning, which led to an alteration of Asp to Tyr at residue 262 in B glycosyltransferase. Like the ABO*BW.17 (D262Y), D262N also significantly de-creased ABO*B.01 expression and lead to GTB destabilizing.</p><p><strong>Conclusions: </strong>The novel B allele with 784G>T caused an alteration of Asp to Tyr at residue 262 in B glycosyltransferase, affecting the expression of GTB protein and influencing GTB structural instability.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Vitro Protective Effects of Total Extract and Fractions of Fenugreek (Trigonella Foenum-Graecum L.) on Red Blood Cells. 胡芦巴(Trigonella Foenum-Graecum L.)总提取物和馏分对红细胞的体外保护作用。
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240421
Iman Morshedi

Background: Erythrocytes are susceptible to oxidative stress throughout their lifespan. While compounds like vitamin C can help mitigate oxidative stress, the exploration of natural herbal products continues to be a compelling area of research. To examine the impact of subfractions derived from acidified chloroform fractions of fenugreek (Trigonella foenum-graecum L.) on red blood cells in the presence of H2O2 as an oxidant, we assessed the factors associated with erythrocyte aging and oxidative stress.

Methods: The maceration technique was employed for extracting fenugreek seeds. Through chromatography, a total of 12 subfractions were isolated from the acidified chloroform extract of fenugreek seeds. Following an initial assessment, four subfractions exhibiting lower erythrocyte toxicity were chosen for further investigation. The objective was to evaluate their impact on erythrocyte aging by measuring the levels of phosphatidylserine (PS), sialic acid, CD47 on the erythrocyte surface, as well as oxidative stress biomarkers. The obtained results were presented as mean ± standard deviation (SD), and data analysis was performed by using ANOVA.

Results: The results of this study revealed, that among the 12 subfractions derived from the acidified chloroform fraction of fenugreek, four subfractions demonstrated protective effects against H2O2-induced hemolysis and oxidative stress. Furthermore, flow cytometry analysis indicated that treatment with three of these subfractions led to elevated levels of CD47 and reduced levels of phosphatidylserine on the surface of erythrocytes.

Conclusions: The results suggest that the subfractions of fenugreek extract which likely contain a higher concentration of flavonoids and a lower content of saponins could be responsible for the observed protection against erythrocyte aging processes. It appears that fenugreek seeds have the ability to safeguard human erythrocytes from oxidative damage by reducing oxidative stress, preserving the activity of antioxidative enzymes, and maintaining the integrity of erythrocyte structure.

背景:红细胞在整个生命周期中都容易受到氧化应激的影响。虽然维生素 C 等化合物有助于减轻氧化应激,但天然草药产品的探索仍然是一个引人注目的研究领域。为了研究在 H2O2 作为氧化剂存在的情况下,从葫芦巴(Trigonella foenum-graecum L.)的酸化氯仿馏分中提取的亚馏分对红细胞的影响,我们评估了与红细胞衰老和氧化应激相关的因素:方法:采用浸渍技术提取葫芦巴种子。方法:采用浸渍技术提取葫芦巴种子,通过色谱法从酸化的氯仿提取物中分离出 12 个亚组分。经过初步评估,选择了四种红细胞毒性较低的亚馏分进行进一步研究。目的是通过测量红细胞表面的磷脂酰丝氨酸(PS)、硅铝酸、CD47 以及氧化应激生物标志物的水平,评估它们对红细胞老化的影响。研究结果以均数±标准差(SD)表示,数据分析采用方差分析:研究结果表明,在从葫芦巴酸化氯仿馏分中提取的 12 个亚馏分中,有 4 个亚馏分对 H2O2 诱导的溶血和氧化应激具有保护作用。此外,流式细胞术分析表明,用其中三种亚萃取物处理后,红细胞表面的 CD47 水平升高,磷脂酰丝氨酸水平降低:研究结果表明,葫芦巴提取物中黄酮类化合物含量较高,皂苷含量较低的亚萃取物可能是保护红细胞不衰老的原因。由此看来,葫芦巴种子能够通过减少氧化应激、保持抗氧化酶的活性和维持红细胞结构的完整性来保护人类红细胞免受氧化损伤。
{"title":"In Vitro Protective Effects of Total Extract and Fractions of Fenugreek (Trigonella Foenum-Graecum L.) on Red Blood Cells.","authors":"Iman Morshedi","doi":"10.7754/Clin.Lab.2024.240421","DOIUrl":"10.7754/Clin.Lab.2024.240421","url":null,"abstract":"<p><strong>Background: </strong>Erythrocytes are susceptible to oxidative stress throughout their lifespan. While compounds like vitamin C can help mitigate oxidative stress, the exploration of natural herbal products continues to be a compelling area of research. To examine the impact of subfractions derived from acidified chloroform fractions of fenugreek (Trigonella foenum-graecum L.) on red blood cells in the presence of H2O2 as an oxidant, we assessed the factors associated with erythrocyte aging and oxidative stress.</p><p><strong>Methods: </strong>The maceration technique was employed for extracting fenugreek seeds. Through chromatography, a total of 12 subfractions were isolated from the acidified chloroform extract of fenugreek seeds. Following an initial assessment, four subfractions exhibiting lower erythrocyte toxicity were chosen for further investigation. The objective was to evaluate their impact on erythrocyte aging by measuring the levels of phosphatidylserine (PS), sialic acid, CD47 on the erythrocyte surface, as well as oxidative stress biomarkers. The obtained results were presented as mean ± standard deviation (SD), and data analysis was performed by using ANOVA.</p><p><strong>Results: </strong>The results of this study revealed, that among the 12 subfractions derived from the acidified chloroform fraction of fenugreek, four subfractions demonstrated protective effects against H2O2-induced hemolysis and oxidative stress. Furthermore, flow cytometry analysis indicated that treatment with three of these subfractions led to elevated levels of CD47 and reduced levels of phosphatidylserine on the surface of erythrocytes.</p><p><strong>Conclusions: </strong>The results suggest that the subfractions of fenugreek extract which likely contain a higher concentration of flavonoids and a lower content of saponins could be responsible for the observed protection against erythrocyte aging processes. It appears that fenugreek seeds have the ability to safeguard human erythrocytes from oxidative damage by reducing oxidative stress, preserving the activity of antioxidative enzymes, and maintaining the integrity of erythrocyte structure.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142589316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pedigree Analysis of Maturity-Onset Diabetes of the Young: ABCC8 Mutations? 成熟期发病的青年糖尿病的血统分析:ABCC8 基因突变?
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240537
Xiaofang Fan, Lingxiao Wang, Pingping Hong

Background: Maturity-Onset Diabetes of the Young (MODY) is an autosomal dominant disease, caused by muta-tions in the ABCC8 gene, chromosome 11.

Methods: A case suspected of MODY due to an ABCC8 mutation was examined using whole-genome exon high-throughput sequencing. Selected variant sites were validated via Sanger sequencing.

Results: A heterozygous mutation c.2060C>T (p.T687M) in exon 15 of the ABCC8 gene (Chr11-174494701) was identified in both the proband and the father. This mutation was initially linked to MODY based on clinical fea¬tures.

Conclusions: For patients with high suspicion of MODY, genetic test should conducted to improve their quality of life.

背景:青年期成熟型糖尿病(MODY)是一种常染色体显性遗传病:青年成熟期糖尿病(MODY)是一种常染色体显性遗传病,由 11 号染色体 ABCC8 基因突变引起:方法:采用全基因组外显子高通量测序法对一例因 ABCC8 基因突变而疑似患有 MODY 的病例进行了检测。通过桑格测序验证了所选的变异位点:结果:在疑似患者及其父亲的 ABCC8 基因(Chr11-174494701)第 15 号外显子中发现了一个 c.2060C>T (p.T687M) 杂合突变。根据临床表现,该基因突变最初与 MODY 有关:结论:对于高度怀疑患有 MODY 的患者,应进行基因检测,以提高他们的生活质量。
{"title":"Pedigree Analysis of Maturity-Onset Diabetes of the Young: ABCC8 Mutations?","authors":"Xiaofang Fan, Lingxiao Wang, Pingping Hong","doi":"10.7754/Clin.Lab.2024.240537","DOIUrl":"10.7754/Clin.Lab.2024.240537","url":null,"abstract":"<p><strong>Background: </strong>Maturity-Onset Diabetes of the Young (MODY) is an autosomal dominant disease, caused by muta-tions in the ABCC8 gene, chromosome 11.</p><p><strong>Methods: </strong>A case suspected of MODY due to an ABCC8 mutation was examined using whole-genome exon high-throughput sequencing. Selected variant sites were validated via Sanger sequencing.</p><p><strong>Results: </strong>A heterozygous mutation c.2060C>T (p.T687M) in exon 15 of the ABCC8 gene (Chr11-174494701) was identified in both the proband and the father. This mutation was initially linked to MODY based on clinical fea¬tures.</p><p><strong>Conclusions: </strong>For patients with high suspicion of MODY, genetic test should conducted to improve their quality of life.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142589503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mass Spectrometric and Immunologic Detection of Prolactin-Derived Vasoinhibin in Human Serum. 用质谱和免疫学方法检测人血清中催乳素衍生的血管抑制素
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2023.240635
Jakob Triebel, David Harris, Nils Davies, Johannes Ebnet, Leon Neugebauer, Christin Friedrich, Hülya Markl-Hahn, Hans-Herbert Steiner, Thomas Bertsch

Background: Circulating levels of the antiangiogenic protein, vasoinhibin, derived from the proteolytic cleavage of prolactin (PRL), in prolactinoma are unknown, as is the molecular nature of its isoforms. Dimerization of recombinant vasoinhibin has been reported.

Methods: Vasoinhibin in a human serum sample was identified by using preparative electrophoresis with subsequent SDS-PAGE and Western blot analysis, as well as mass spectrometry (MS) and ELISA.

Results: MS identified a partial vasoinhibin sequence in a 14-kDa protein band from human serum, which eluted in the 28-kDa fraction from the preparative electrophoresis. Measurement of vasoinhibin levels by ELISA identified a concentration of 284 ng/mL at a PRL level of 9,850 ng/mL. Recombinant human vasoinhibin demonstrated dimerization and multimerization when analyzed directly by SDS-PAGE and Western blot analysis under reducing and non-reducing conditions, as well as after immunoprecipitation.

Conclusions: The vasoinhibin sequence was identified in a higher molecular weight fraction, corroborating experi-mental evidence showing the dimerization and aggregation of recombinant human vasoinhibin. This report is sig-nificant, regarding the higher risk of cardiovascular disease and mortality in male patients with hyperprolactin-emia as well as emerging reports of linking PRL and vasoinhibin levels in patients with prolactinoma with left ventricular dysfunction and Takotsubo syndrome.

背景:催乳素瘤中抗血管生成蛋白血管抑制素(由催乳素(PRL)蛋白水解而来)的循环水平及其同工型的分子性质尚不清楚。重组血管抑制素的二聚化已有报道:方法:通过制备电泳、随后的 SDS-PAGE 和 Western 印迹分析以及质谱法(MS)和酶联免疫吸附法,对人血清样本中的血管抑制素进行鉴定:结果:质谱在人血清的 14 kDa 蛋白条带中鉴定出了部分血管抑制素序列,该序列在制备电泳的 28 kDa 部分中洗脱出来。用酶联免疫吸附法测定血管抑制素水平时发现,在PRL水平为9850纳克/毫升时,血管抑制素的浓度为284纳克/毫升。在还原和非还原条件下,以及在免疫沉淀后,重组人血管抑制素直接通过SDS-PAGE和Western印迹分析显示出二聚化和多聚化:结论:在分子量较高的部分中发现了血管抑制素序列,证实了重组人血管抑制素二聚化和聚集的经验证据。该报告意义重大,因为男性高催乳素血症患者罹患心血管疾病和死亡的风险较高,而且新的报告显示,催乳素瘤患者的 PRL 和血管抑制素水平与左心室功能障碍和塔克次氏综合征有关。
{"title":"Mass Spectrometric and Immunologic Detection of Prolactin-Derived Vasoinhibin in Human Serum.","authors":"Jakob Triebel, David Harris, Nils Davies, Johannes Ebnet, Leon Neugebauer, Christin Friedrich, Hülya Markl-Hahn, Hans-Herbert Steiner, Thomas Bertsch","doi":"10.7754/Clin.Lab.2023.240635","DOIUrl":"10.7754/Clin.Lab.2023.240635","url":null,"abstract":"<p><strong>Background: </strong>Circulating levels of the antiangiogenic protein, vasoinhibin, derived from the proteolytic cleavage of prolactin (PRL), in prolactinoma are unknown, as is the molecular nature of its isoforms. Dimerization of recombinant vasoinhibin has been reported.</p><p><strong>Methods: </strong>Vasoinhibin in a human serum sample was identified by using preparative electrophoresis with subsequent SDS-PAGE and Western blot analysis, as well as mass spectrometry (MS) and ELISA.</p><p><strong>Results: </strong>MS identified a partial vasoinhibin sequence in a 14-kDa protein band from human serum, which eluted in the 28-kDa fraction from the preparative electrophoresis. Measurement of vasoinhibin levels by ELISA identified a concentration of 284 ng/mL at a PRL level of 9,850 ng/mL. Recombinant human vasoinhibin demonstrated dimerization and multimerization when analyzed directly by SDS-PAGE and Western blot analysis under reducing and non-reducing conditions, as well as after immunoprecipitation.</p><p><strong>Conclusions: </strong>The vasoinhibin sequence was identified in a higher molecular weight fraction, corroborating experi-mental evidence showing the dimerization and aggregation of recombinant human vasoinhibin. This report is sig-nificant, regarding the higher risk of cardiovascular disease and mortality in male patients with hyperprolactin-emia as well as emerging reports of linking PRL and vasoinhibin levels in patients with prolactinoma with left ventricular dysfunction and Takotsubo syndrome.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142589376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Rare Imported Plasmodium ovale Infection in Shaoxing. 绍兴一例罕见的输入性卵形疟原虫感染病例。
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240610
Guojian Shen, Qing Wang

Background: Malaria is a global disease caused by the transmission of the malaria parasite through the bites of infected Anopheles mosquitoes. There are 4 kinds of common malaria parasites, among which oval malaria is mainly prevalent in tropical West Africa, with a narrow distribution range, mainly imported cases in China, which is relatively rare. Because the morphology, attack cycle, recrudescence and relapse are similar to those of Plasmodium vivax and, therefore, is easily missed and misdiagnosed.

Methods: Malaria parasite-specific antigens were detected in whole blood samples using rapid diagnostic tests (RDT). Peripheral blood was used to prepare thick and thin smears, which were then stained with Giemsa for the identification of malaria parasites and different parasite morphologies under an oil microscope. Plasmodium species were identified using fluorescence quantitative PCR.

Results: The patient's RDT revealed two red response lines (only T2 positive), indicating a single or mixed infection of three types of malaria (Plasmodium vivax, Plasmodium malarie, Plasmodium ovale) excluding Plasmodium falciparum. Thick smears exhibited various stages of Plasmodium such as hypertrophic rings and gametocytes, while thin films displayed Plasmodium trophozoites, gametocytes, etc., resembling oval malaria. The patients were diagnosed with Plasmodium ovum infection through fluorescence quantitative PCR, and targeted treatment was administered.

Conclusions: The incidence of Plasmodium ovum infection is low, and there is a risk of overlooking or misdiagnosing the infection in laboratory tests. It is essential for laboratory staff to enhance their morphological recognition skills for Plasmodium and to integrate blood routine analysis, RDT, and PCR results in order to facilitate early diagnosis and prompt treatment.

背景:疟疾是一种全球性疾病,由疟原虫通过受感染的按蚊叮咬传播引起。常见的疟原虫有 4 种,其中卵形疟主要流行于热带西非,分布范围较窄,我国以输入性病例为主,较为少见。由于其形态、发作周期、复发和复发与间日疟相似,因此容易漏诊和误诊:方法:使用快速诊断测试(RDT)检测全血样本中的疟原虫特异性抗原。用外周血制备厚涂片和薄涂片,然后用革兰染色,在油镜下鉴定疟原虫和不同的寄生虫形态。使用荧光定量 PCR 鉴定疟原虫种类:患者的 RDT 显示两条红色反应线(仅 T2 呈阳性),表明其感染了三种类型的疟疾(间日疟原虫、恶性疟原虫、卵形疟原虫),但不包括恶性疟原虫。厚涂片显示不同阶段的疟原虫,如肥大环和配子细胞,而薄片则显示滋养体疟原虫、配子细胞等,类似卵圆形疟疾。患者通过荧光定量 PCR 诊断为卵形疟原虫感染,并进行了针对性治疗:结论:卵形疟原虫感染的发病率较低,在实验室检测中存在漏诊或误诊的风险。实验室工作人员必须提高对疟原虫的形态学识别能力,并将血常规分析、RDT 和 PCR 结果结合起来,以促进早期诊断和及时治疗。
{"title":"A Case of Rare Imported Plasmodium ovale Infection in Shaoxing.","authors":"Guojian Shen, Qing Wang","doi":"10.7754/Clin.Lab.2024.240610","DOIUrl":"10.7754/Clin.Lab.2024.240610","url":null,"abstract":"<p><strong>Background: </strong>Malaria is a global disease caused by the transmission of the malaria parasite through the bites of infected Anopheles mosquitoes. There are 4 kinds of common malaria parasites, among which oval malaria is mainly prevalent in tropical West Africa, with a narrow distribution range, mainly imported cases in China, which is relatively rare. Because the morphology, attack cycle, recrudescence and relapse are similar to those of Plasmodium vivax and, therefore, is easily missed and misdiagnosed.</p><p><strong>Methods: </strong>Malaria parasite-specific antigens were detected in whole blood samples using rapid diagnostic tests (RDT). Peripheral blood was used to prepare thick and thin smears, which were then stained with Giemsa for the identification of malaria parasites and different parasite morphologies under an oil microscope. Plasmodium species were identified using fluorescence quantitative PCR.</p><p><strong>Results: </strong>The patient's RDT revealed two red response lines (only T2 positive), indicating a single or mixed infection of three types of malaria (Plasmodium vivax, Plasmodium malarie, Plasmodium ovale) excluding Plasmodium falciparum. Thick smears exhibited various stages of Plasmodium such as hypertrophic rings and gametocytes, while thin films displayed Plasmodium trophozoites, gametocytes, etc., resembling oval malaria. The patients were diagnosed with Plasmodium ovum infection through fluorescence quantitative PCR, and targeted treatment was administered.</p><p><strong>Conclusions: </strong>The incidence of Plasmodium ovum infection is low, and there is a risk of overlooking or misdiagnosing the infection in laboratory tests. It is essential for laboratory staff to enhance their morphological recognition skills for Plasmodium and to integrate blood routine analysis, RDT, and PCR results in order to facilitate early diagnosis and prompt treatment.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance of Antimicrobial Resistance Bacteria in a Healthcare Facility at an Industrial Site in Saudi Arabia. 沙特阿拉伯工业基地医疗设施中抗菌药耐药性细菌的监测。
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240433
Ahmed M Tolah, Faris A Alnomani, Samer M Albeladi, Abdelrahman A Abdelwarth, Alyaa M Mukhtar, Hamza H Habeeballah, Hanadi T Ahmedah, Muhammad Yasir, Esam I Azhar

Background: This study aimed to perform surveillance and identify antimicrobial resistance (AMR) in the most common pathogenic bacteria in a healthcare facility in Rabigh City, Saudi Arabia.

Methods: A total of 1,933 samples were processed from patients during the study period from January 2022 to June 2022. Identification and antimicrobial susceptibility of the cultured isolates were performed using the MicroScan system.

Results: Out of the 1,933 tested samples, 11.1% (n = 214) were positive for bacterial growth. A relatively higher percentage of isolates was recovered from patients older than 50 years (55.9%). Gram-negative bacteria (67.3%) were significantly more prevalent than Gram-positive bacteria (32.7%). The Gram-negative pathogenic bacteria comprised mainly Escherichia coli and Klebsiella pneumoniae, followed by Pseudomonas aeruginosa. Staphylococ-cus epidermidis and coagulase-negative staphylococci were found at relatively high abundance in Gram-positive bacteria. Increased resistance to carbapenem antibiotics was observed in K. pneumoniae. In Gram-positive bac¬teria, > 50% of the isolates of S. epidermidis were resistant to 13 tested antimicrobial agents.

Conclusions: This study provided an overview of the distribution of pathogenic bacteria and antimicrobial susceptibility of the prevalent Gram-negative and Gram-positive pathogenic bacteria in a major healthcare facility in Saudi Arabia. It highlights the importance of continuously monitoring AMR bacteria in healthcare settings to ensure the effective use of antibiotics for treatment.

背景:本研究旨在对沙特阿拉伯拉比格市医疗机构中最常见的致病菌进行监测并确定其抗菌药耐药性:本研究旨在对沙特阿拉伯拉比格市一家医疗机构中最常见的致病菌进行监测并确定其抗菌药耐药性(AMR):在 2022 年 1 月至 2022 年 6 月的研究期间,共处理了 1,933 份患者样本。使用 MicroScan 系统对培养分离的细菌进行鉴定并检测其抗菌药敏感性:在 1,933 份检测样本中,11.1%(n = 214)的细菌生长呈阳性。从 50 岁以上患者身上分离出的细菌比例相对较高(55.9%)。革兰氏阴性菌(67.3%)明显多于革兰氏阳性菌(32.7%)。革兰氏阴性致病菌主要包括大肠埃希菌和肺炎克雷伯菌,其次是铜绿假单胞菌。在革兰氏阳性细菌中,表皮葡萄球菌和凝固酶阴性葡萄球菌的数量相对较多。肺炎双球菌对碳青霉烯类抗生素的耐药性增强。在革兰氏阳性细菌中,50%以上的表皮葡萄球菌分离株对 13 种测试过的抗菌药物具有耐药性:这项研究概述了沙特阿拉伯一家大型医疗机构中致病菌的分布情况以及流行的革兰氏阴性和革兰氏阳性致病菌对抗菌药的敏感性。它强调了在医疗机构中持续监测 AMR 细菌以确保有效使用抗生素进行治疗的重要性。
{"title":"Surveillance of Antimicrobial Resistance Bacteria in a Healthcare Facility at an Industrial Site in Saudi Arabia.","authors":"Ahmed M Tolah, Faris A Alnomani, Samer M Albeladi, Abdelrahman A Abdelwarth, Alyaa M Mukhtar, Hamza H Habeeballah, Hanadi T Ahmedah, Muhammad Yasir, Esam I Azhar","doi":"10.7754/Clin.Lab.2024.240433","DOIUrl":"10.7754/Clin.Lab.2024.240433","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to perform surveillance and identify antimicrobial resistance (AMR) in the most common pathogenic bacteria in a healthcare facility in Rabigh City, Saudi Arabia.</p><p><strong>Methods: </strong>A total of 1,933 samples were processed from patients during the study period from January 2022 to June 2022. Identification and antimicrobial susceptibility of the cultured isolates were performed using the MicroScan system.</p><p><strong>Results: </strong>Out of the 1,933 tested samples, 11.1% (n = 214) were positive for bacterial growth. A relatively higher percentage of isolates was recovered from patients older than 50 years (55.9%). Gram-negative bacteria (67.3%) were significantly more prevalent than Gram-positive bacteria (32.7%). The Gram-negative pathogenic bacteria comprised mainly Escherichia coli and Klebsiella pneumoniae, followed by Pseudomonas aeruginosa. Staphylococ-cus epidermidis and coagulase-negative staphylococci were found at relatively high abundance in Gram-positive bacteria. Increased resistance to carbapenem antibiotics was observed in K. pneumoniae. In Gram-positive bac¬teria, > 50% of the isolates of S. epidermidis were resistant to 13 tested antimicrobial agents.</p><p><strong>Conclusions: </strong>This study provided an overview of the distribution of pathogenic bacteria and antimicrobial susceptibility of the prevalent Gram-negative and Gram-positive pathogenic bacteria in a major healthcare facility in Saudi Arabia. It highlights the importance of continuously monitoring AMR bacteria in healthcare settings to ensure the effective use of antibiotics for treatment.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142589689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nursing Management Strategies to Improve the Qualified Rate of Clinical Microbial Specimens. 提高临床微生物标本合格率的护理管理策略。
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240614
Hongmei Chen, Hui Cong

Background: The purpose of clinical microbiology testing is to provide important information for clinical diagnosis and treatment. The correct collection, processing, and transportation of specimens are the key to the success of clinical microbiological examination.

Methods: Retrospective analysis was done on the composition and causes of unqualified microbial samples submitted by clinical departments from 2019 to 2020 at the Affiliated Hospital of Nantong University. The solutions were proposed from the perspective of nursing management.

Results: In 2019, the hospital received 64,244 clinical microbial specimens. The unqualified rate of samples was 8.96%, of which the unqualified sputum accounted for 84.74%. After strengthening the communication with the medical laboratory, increasing publicity and training, and improving the information system and other auxiliary monitoring functions, the unqualified rate of clinical microbial specimens was reduced to 6.05% in 2020.

Conclusions: Continuously improving the theoretical and practical abilities of nurses can reduce the unqualified rate of samples.

背景:临床微生物检验的目的是为临床诊断和治疗提供重要信息。标本的正确采集、处理和运输是临床微生物检验成功的关键:对南通大学附属医院2019年至2020年临床科室送检微生物不合格标本的构成及原因进行回顾性分析。结果:2019年,医院共接收临床微生物标本64244份。标本不合格率为8.96%,其中痰液不合格占84.74%。加强与医学检验科的沟通,加大宣传培训力度,完善信息系统等辅助监测功能后,2020年临床微生物标本不合格率降至6.05%:结论:不断提高护士的理论和实践能力可以降低标本的不合格率。
{"title":"Nursing Management Strategies to Improve the Qualified Rate of Clinical Microbial Specimens.","authors":"Hongmei Chen, Hui Cong","doi":"10.7754/Clin.Lab.2024.240614","DOIUrl":"10.7754/Clin.Lab.2024.240614","url":null,"abstract":"<p><strong>Background: </strong>The purpose of clinical microbiology testing is to provide important information for clinical diagnosis and treatment. The correct collection, processing, and transportation of specimens are the key to the success of clinical microbiological examination.</p><p><strong>Methods: </strong>Retrospective analysis was done on the composition and causes of unqualified microbial samples submitted by clinical departments from 2019 to 2020 at the Affiliated Hospital of Nantong University. The solutions were proposed from the perspective of nursing management.</p><p><strong>Results: </strong>In 2019, the hospital received 64,244 clinical microbial specimens. The unqualified rate of samples was 8.96%, of which the unqualified sputum accounted for 84.74%. After strengthening the communication with the medical laboratory, increasing publicity and training, and improving the information system and other auxiliary monitoring functions, the unqualified rate of clinical microbial specimens was reduced to 6.05% in 2020.</p><p><strong>Conclusions: </strong>Continuously improving the theoretical and practical abilities of nurses can reduce the unqualified rate of samples.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142589414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prevalence of Transfusion-Transmitted Infections and Nucleic Acid Testing Among Blood Donors in Makkah, Saudi Arabia. 沙特阿拉伯麦加献血者的输血传播感染率和核酸检测。
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240915
Mohammad H Albshri, Ahmad A Ghoth, Abdulqader A Mutwalli, Naif S Alzahrani, Samer S Bahattab, Bassam A Hanbali, Mohammed H Althaqafi, Abdulaziz M Alqarni, Mansor M Alsulimani, Naif K Alzahrani, Fahad S Alharbi, Wafaa H Alansari, Abdulelah A Ekram, Ali A Alghamdi, Mansour A Alzahrani
<p><strong>Background: </strong>Despite saving a vast number of lives through blood transfusions, transfusion-transmitted infections (TTIs) still threaten the lives of people needing blood transfusion. Hence, screening blood donors and reviewing the prevalence of TTIs amongst blood donors might show the impact of these infections among our people. The aim of this study was to evaluate the prevalence rates of transfusion-transmitted infections among blood donors in Makkah as foundation for providing harmless blood transfusion in Makkah, Saudi Arabia.</p><p><strong>Methods: </strong>A retrospective study was carried out at the Central Blood Bank in Makkah city, Saudi Arabia, from January 1, 2023, to December 31, 2023. A total of 13,706 samples were collected and screened for hepatitis B surface antigen (HBsAg), hepatitis B surface antibodies (HBsAbs), hepatitis B core antibodies (HBcAbs), antibodies to hepatitis C virus (anti-HCV), antibodies to HIV 1 and 2 (HIV I/II Ab), antibodies to HTLV 1 and 2 (HTLV I/II Ab), Malarial antibodies, and antibodies to VDRL.</p><p><strong>Results: </strong>A total of 13,706 blood units were received and tested. Out of the total, 52% were non-Saudi donors and 47.9% were Saudi donors; 28.4% were aged 18 - 28 years, 42.8% were aged 29 - 39 years, 24.4% were aged 40 - 50 years, and 4.4% were aged 51 - 60 years. The majority was O+ blood group (42.7%), followed by A+ (26.2%), B+ (18.7%), AB+ (4.6%), O- (3.8%), A- (2.1%), B- (1.5%), and AB- (0.4%). While 42.6% of the blood units donated were from voluntary donors, 57.4% were donated by replacement donors. Sixty-one samples (0.4%) tested positive for HBsAg, 824 samples (6%) for HBcAb, 43 samples (0.3%) for HCV antibodies, 754 samples (5.5%) for HBsAb, and 44 samples (0.3%) for HIV I/II Ag/Ab combinations. Further, 44 samples (0.3%) were positive for HTLV I/II antibodies, 83 samples (0.6%) for VDRL antibodies, and only 3 samples (nearly 0%) for malaria antibodies. Forty-three samples (0.3%) were positive for NAT-HBV, 7 samples (0.1%) were positive for NAT-HCV, and 6 samples (0.1%) were positive for NAT-HIV. The analysis revealed a statistically significant and strong correlation between HBsAgs and NAT-HBV (r = 0.819, p < 0.0001). In contrast, while there was a statistically significant association between HBsAgs and HBcAbs, the correlation was weak (r = 0.191, p < 0.0001). Additionally, there was an association between HBsAbs and HBsAgs, but the Spearman correlation indicated a very weak relationship (r = 0.042, p < 0.0001).</p><p><strong>Conclusions: </strong>Prevalence rates of transfusion-transmitted infections showed a steady decline in 2023, and these rates were much lower in Makkah than in other parts of the country or in neighboring countries. The importance of using NAT in the screening of blood donors was indicated in this study. These findings could contribute to improving the understanding of TTIs epidemiology and supporting health authorities in controlling blo
背景:尽管输血挽救了大量生命,但输血传播感染(TTIs)仍然威胁着需要输血者的生命。因此,对献血者进行筛查并审查输血传播感染在献血者中的流行情况可能会显示出这些感染对我国人民的影响。本研究旨在评估麦加献血者中输血传播感染的流行率,为在沙特阿拉伯麦加提供无害输血奠定基础:从 2023 年 1 月 1 日至 2023 年 12 月 31 日,在沙特阿拉伯麦加市中央血库开展了一项回顾性研究。共采集了 13706 份样本,并对其进行了乙肝表面抗原 (HBsAg)、乙肝表面抗体 (HBsAbs)、乙肝核心抗体 (HBcAbs)、丙肝病毒抗体 (抗-HCV)、HIV 1 和 2 抗体 (HIV I/II Ab)、HTLV 1 和 2 抗体 (HTLV I/II Ab)、疟疾抗体和 VDRL 抗体的筛查:共收到并检测了 13 706 个血液单位。其中,非沙特籍献血者占 52%,沙特籍献血者占 47.9%;年龄在 18 - 28 岁之间的献血者占 28.4%,29 - 39 岁之间的献血者占 42.8%,40 - 50 岁之间的献血者占 24.4%,51 - 60 岁之间的献血者占 4.4%。大多数人是 O+ 血型(42.7%),其次是 A+(26.2%)、B+(18.7%)、AB+(4.6%)、O-(3.8%)、A-(2.1%)、B-(1.5%)和 AB-(0.4%)。42.6%的献血单位来自自愿献血者,57.4%来自替代献血者。61 个样本(0.4%)的 HBsAg 检测呈阳性,824 个样本(6%)的 HBcAb 检测呈阳性,43 个样本(0.3%)的 HCV 抗体检测呈阳性,754 个样本(5.5%)的 HBsAb 检测呈阳性,44 个样本(0.3%)的 HIV I/II Ag/Ab 组合检测呈阳性。此外,44 个样本(0.3%)的 HTLV I/II 抗体呈阳性,83 个样本(0.6%)的 VDRL 抗体呈阳性,只有 3 个样本(近 0%)的疟疾抗体呈阳性。43份样本(0.3%)NAT-HBV呈阳性,7份样本(0.1%)NAT-HCV呈阳性,6份样本(0.1%)NAT-HIV呈阳性。分析表明,HBsAgs 与 NAT-HBV 之间存在统计学意义上的显著强相关性(r = 0.819,p < 0.0001)。相比之下,虽然 HBsAgs 和 HBcAbs 之间存在统计学意义上的显著关联,但相关性较弱(r = 0.191,p < 0.0001)。此外,HBsAbs 和 HBsAgs 之间也有关联,但斯皮尔曼相关性表明两者之间的关系很弱(r = 0.042,p < 0.0001):2023年,输血传播感染率呈稳步下降趋势,麦加的感染率远低于该国其他地区或邻国。这项研究表明,使用 NAT 筛查献血者非常重要。这些发现有助于加深人们对 TTIs 流行病学的了解,并支持卫生部门控制血液传播的病症。
{"title":"The Prevalence of Transfusion-Transmitted Infections and Nucleic Acid Testing Among Blood Donors in Makkah, Saudi Arabia.","authors":"Mohammad H Albshri, Ahmad A Ghoth, Abdulqader A Mutwalli, Naif S Alzahrani, Samer S Bahattab, Bassam A Hanbali, Mohammed H Althaqafi, Abdulaziz M Alqarni, Mansor M Alsulimani, Naif K Alzahrani, Fahad S Alharbi, Wafaa H Alansari, Abdulelah A Ekram, Ali A Alghamdi, Mansour A Alzahrani","doi":"10.7754/Clin.Lab.2024.240915","DOIUrl":"10.7754/Clin.Lab.2024.240915","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Despite saving a vast number of lives through blood transfusions, transfusion-transmitted infections (TTIs) still threaten the lives of people needing blood transfusion. Hence, screening blood donors and reviewing the prevalence of TTIs amongst blood donors might show the impact of these infections among our people. The aim of this study was to evaluate the prevalence rates of transfusion-transmitted infections among blood donors in Makkah as foundation for providing harmless blood transfusion in Makkah, Saudi Arabia.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective study was carried out at the Central Blood Bank in Makkah city, Saudi Arabia, from January 1, 2023, to December 31, 2023. A total of 13,706 samples were collected and screened for hepatitis B surface antigen (HBsAg), hepatitis B surface antibodies (HBsAbs), hepatitis B core antibodies (HBcAbs), antibodies to hepatitis C virus (anti-HCV), antibodies to HIV 1 and 2 (HIV I/II Ab), antibodies to HTLV 1 and 2 (HTLV I/II Ab), Malarial antibodies, and antibodies to VDRL.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 13,706 blood units were received and tested. Out of the total, 52% were non-Saudi donors and 47.9% were Saudi donors; 28.4% were aged 18 - 28 years, 42.8% were aged 29 - 39 years, 24.4% were aged 40 - 50 years, and 4.4% were aged 51 - 60 years. The majority was O+ blood group (42.7%), followed by A+ (26.2%), B+ (18.7%), AB+ (4.6%), O- (3.8%), A- (2.1%), B- (1.5%), and AB- (0.4%). While 42.6% of the blood units donated were from voluntary donors, 57.4% were donated by replacement donors. Sixty-one samples (0.4%) tested positive for HBsAg, 824 samples (6%) for HBcAb, 43 samples (0.3%) for HCV antibodies, 754 samples (5.5%) for HBsAb, and 44 samples (0.3%) for HIV I/II Ag/Ab combinations. Further, 44 samples (0.3%) were positive for HTLV I/II antibodies, 83 samples (0.6%) for VDRL antibodies, and only 3 samples (nearly 0%) for malaria antibodies. Forty-three samples (0.3%) were positive for NAT-HBV, 7 samples (0.1%) were positive for NAT-HCV, and 6 samples (0.1%) were positive for NAT-HIV. The analysis revealed a statistically significant and strong correlation between HBsAgs and NAT-HBV (r = 0.819, p &lt; 0.0001). In contrast, while there was a statistically significant association between HBsAgs and HBcAbs, the correlation was weak (r = 0.191, p &lt; 0.0001). Additionally, there was an association between HBsAbs and HBsAgs, but the Spearman correlation indicated a very weak relationship (r = 0.042, p &lt; 0.0001).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Prevalence rates of transfusion-transmitted infections showed a steady decline in 2023, and these rates were much lower in Makkah than in other parts of the country or in neighboring countries. The importance of using NAT in the screening of blood donors was indicated in this study. These findings could contribute to improving the understanding of TTIs epidemiology and supporting health authorities in controlling blo","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142589786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causes and Management Strategies for Unusual Hypoglycemia: a Case Series. 异常低血糖的原因和处理策略:病例系列。
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240533
Guoxiang Bao, Jialu Li, Yunan Mei, Cuiying Yang

Background: Glucose levels are vital for indicating the body's sugar content, with imbalances leading to diseases like diabetes or hypoglycemia-related symptoms such as palpitations and fatigue.

Methods: This case series describes three cases of hypoglycemia identified in recent years, utilizing multiple glucose measurement methods and exploring strategies to eliminate interferences.

Results: Two cases of pseudo-hypoglycemia induced by PEGylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) and Evolocumab injections, and one case of true reactive hypoglycemia following a glucose tolerance test in a patient post-gastric bypass surgery.

Conclusions: For unusual hypoglycemia, collaboration with clinicians and multiple methods is crucial for accurate analysis to differentiate true from pseudo-hypoglycemia, ensuring precise diagnosis and optimal clinical service.

背景:葡萄糖水平是人体糖分含量的重要指标,失衡会导致糖尿病等疾病或心悸、乏力等低血糖相关症状:本系列病例描述了近年来发现的三例低血糖症,采用了多种血糖测量方法,并探讨了消除干扰的策略:结果:两例由 PEG 重组人粒细胞集落刺激因子(PEG-rhG-CSF)和 Evolocumab 注射诱发的假性低血糖,一例是胃旁路手术后患者进行葡萄糖耐量试验后出现的真正反应性低血糖:结论:对于异常低血糖,与临床医生合作并采用多种方法进行准确分析是区分真性和假性低血糖的关键,可确保精确诊断和最佳临床服务。
{"title":"Causes and Management Strategies for Unusual Hypoglycemia: a Case Series.","authors":"Guoxiang Bao, Jialu Li, Yunan Mei, Cuiying Yang","doi":"10.7754/Clin.Lab.2024.240533","DOIUrl":"10.7754/Clin.Lab.2024.240533","url":null,"abstract":"<p><strong>Background: </strong>Glucose levels are vital for indicating the body's sugar content, with imbalances leading to diseases like diabetes or hypoglycemia-related symptoms such as palpitations and fatigue.</p><p><strong>Methods: </strong>This case series describes three cases of hypoglycemia identified in recent years, utilizing multiple glucose measurement methods and exploring strategies to eliminate interferences.</p><p><strong>Results: </strong>Two cases of pseudo-hypoglycemia induced by PEGylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) and Evolocumab injections, and one case of true reactive hypoglycemia following a glucose tolerance test in a patient post-gastric bypass surgery.</p><p><strong>Conclusions: </strong>For unusual hypoglycemia, collaboration with clinicians and multiple methods is crucial for accurate analysis to differentiate true from pseudo-hypoglycemia, ensuring precise diagnosis and optimal clinical service.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced Diagnostic Accuracy in Hepatitis B: Human vs. Sheep-Derived Antibodies in HBsAg Confirmatory Testing. 提高乙型肝炎的诊断准确性:HBsAg 确证测试中人与绵羊衍生抗体的对比。
IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-11-01 DOI: 10.7754/Clin.Lab.2024.240527
Seunghwan Kim, Min-Kyung So, Tae-Dong Jeong, Soo-Kyung Kim

Background: HBsAg confirmatory testing is crucial for accurately diagnosing HBV infection and avoiding false positives. We compared the performance of human-derived and sheep-derived anti-HBs reagents in the Elecsys HBsAg confirmatory test (Roche Diagnostics, Germany).

Methods: Samples with a HBsAg COI of 0.9 or more underwent confirmatory testing with both reagents. Results showed a high overall agreement rate of 98% between human and sheep reagents.

Results: The average confirmation percentage with sheep anti-HBs was significantly lower than with human anti-HBs (6.9% vs. 20.0%, p = 0.002). Additionally, some strongly positive HBsAg samples could not be neutralized.

Conclusions: This suggests that the polyclonal antibodies in these reagents have different specificities and affinities for HBsAg epitopes. The findings emphasize the importance of reagent specificity and affinity to ensure accurate HBV diagnosis. Additional HBV markers and clinical context must be considered to confirm the diagnosis.

背景:HBsAg 确诊试验对于准确诊断 HBV 感染和避免假阳性至关重要。我们比较了人源抗 HBs 试剂和羊源抗 HBs 试剂在 Elecsys HBsAg 确证检验(德国罗氏诊断公司)中的性能:方法:对 HBsAg COI 为 0.9 或以上的样本使用两种试剂进行确证检测。结果显示,人和羊试剂的总体一致率高达 98%:结果:羊抗 HBs 的平均确认率明显低于人抗 HBs(6.9% 对 20.0%,P = 0.002)。此外,一些 HBsAg 强阳性样本无法被中和:结论:这表明这些试剂中的多克隆抗体对 HBsAg 表位具有不同的特异性和亲和力。这些发现强调了试剂特异性和亲和力对确保准确诊断 HBV 的重要性。确诊时还必须考虑其他 HBV 标志物和临床背景。
{"title":"Enhanced Diagnostic Accuracy in Hepatitis B: Human vs. Sheep-Derived Antibodies in HBsAg Confirmatory Testing.","authors":"Seunghwan Kim, Min-Kyung So, Tae-Dong Jeong, Soo-Kyung Kim","doi":"10.7754/Clin.Lab.2024.240527","DOIUrl":"10.7754/Clin.Lab.2024.240527","url":null,"abstract":"<p><strong>Background: </strong>HBsAg confirmatory testing is crucial for accurately diagnosing HBV infection and avoiding false positives. We compared the performance of human-derived and sheep-derived anti-HBs reagents in the Elecsys HBsAg confirmatory test (Roche Diagnostics, Germany).</p><p><strong>Methods: </strong>Samples with a HBsAg COI of 0.9 or more underwent confirmatory testing with both reagents. Results showed a high overall agreement rate of 98% between human and sheep reagents.</p><p><strong>Results: </strong>The average confirmation percentage with sheep anti-HBs was significantly lower than with human anti-HBs (6.9% vs. 20.0%, p = 0.002). Additionally, some strongly positive HBsAg samples could not be neutralized.</p><p><strong>Conclusions: </strong>This suggests that the polyclonal antibodies in these reagents have different specificities and affinities for HBsAg epitopes. The findings emphasize the importance of reagent specificity and affinity to ensure accurate HBV diagnosis. Additional HBV markers and clinical context must be considered to confirm the diagnosis.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 11","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical laboratory
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1